Quick answers
- What is Vivimusta?
- Vivimusta is a brand name of Bendamustine hydrochloride, a prescription medicine. The FDA NDC Directory lists 2 Vivimusta products in 1 strength and form.
- Who makes Vivimusta?
- Azurity holds the FDA application for Vivimusta (NDA212209, approved December 7, 2022). 1 other company (repackagers or distributors) also list Vivimusta products.
- Is there a generic or store brand of Vivimusta?
- Other products of Bendamustine hydrochloride are listed with the FDA, but none in exactly the same strength and form as a Vivimusta product.
- Has Vivimusta been recalled?
- No recall linked to Vivimusta products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Vivimusta is
Each Vivimusta product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Bendamustine hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| bendamustine hydrochloride 25 mg/mL injection (intravenous) | Vivimusta | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Bendamustine hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA212209 | Azurity | December 7, 2022 | 2 |
Companies that list Vivimusta
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Vivimusta products.
- Azurity Pharmaceuticals, Inc.1 product
- Slayback Pharma LLC1 product
Recalls
No recall linked to Vivimusta products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.